Martin Fan
Stock Analyst at Wedbush
(4.75)
# 670
Out of 5,090 analysts
67
Total ratings
48%
Success rate
44.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZURA Zura Bio | Reiterated: Buy | $22 | $4.04 | +444.55% | 5 | Oct 27, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $70 | $45.08 | +55.28% | 5 | Oct 13, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $23.76 | $9.52 | +149.54% | 2 | Oct 1, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Buy | $45 | $28.39 | +58.51% | 5 | Sep 30, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $165 | $96.87 | +70.33% | 6 | Sep 24, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Hold | $80 → $50 | $38.87 | +28.63% | 5 | Sep 23, 2026 | |
| IMUX Immunic | Reiterated: Buy | $45 | $7.51 | +499.20% | 2 | Sep 10, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | $38 | $6.49 | +485.52% | 7 | Aug 18, 2026 | |
| VOR Vor Biopharma | Reiterated: Hold | $18 → $27 | $19.68 | +37.20% | 4 | Aug 12, 2026 | |
| SANA Sana Biotechnology | Reiterated: Buy | $7 | $2.57 | +172.37% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $4.10 | -51.22% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.19 | +854.65% | 3 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.08 | +236.54% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.97 | +151.89% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $50.61 | -9.11% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $45 | $48.28 | n/a | 2 | Aug 7, 2025 |
Zura Bio
Oct 27, 2026
Reiterated: Buy
Price Target: $22
Current: $4.04
Upside: +444.55%
First Tracks Biotherapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $70
Current: $45.08
Upside: +55.28%
Eupraxia Pharmaceuticals Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $23.76
Current: $9.52
Upside: +149.54%
Zenas BioPharma
Sep 30, 2026
Reiterated: Buy
Price Target: $45
Current: $28.39
Upside: +58.51%
Oruka Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $165
Current: $96.87
Upside: +70.33%
Nektar Therapeutics
Sep 23, 2026
Reiterated: Hold
Price Target: $80 → $50
Current: $38.87
Upside: +28.63%
Immunic
Sep 10, 2026
Reiterated: Buy
Price Target: $45
Current: $7.51
Upside: +499.20%
Cartesian Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $38
Current: $6.49
Upside: +485.52%
Vor Biopharma
Aug 12, 2026
Reiterated: Hold
Price Target: $18 → $27
Current: $19.68
Upside: +37.20%
Sana Biotechnology
Aug 11, 2026
Reiterated: Buy
Price Target: $7
Current: $2.57
Upside: +172.37%
Aug 6, 2026
Reiterated: Sell
Price Target: $2
Current: $4.10
Upside: -51.22%
May 21, 2026
Reiterated: Buy
Price Target: $40
Current: $4.19
Upside: +854.65%
May 14, 2026
Reiterated: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $3.97
Upside: +151.89%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $50.61
Upside: -9.11%
Aug 7, 2025
Reiterated: Buy
Price Target: $40 → $45
Current: $48.28
Upside: n/a